From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio

J Invest Dermatol. 2021 Dec;141(12):2791-2796. doi: 10.1016/j.jid.2021.05.024. Epub 2021 Jul 15.

Abstract

Despite thousands of reported patients with pandemic-associated pernio, low rates of seroconversion and PCR positivity have defied causative linkage to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pernio in uninfected children is associated with monogenic disorders of excessive IFN-1 immunity, whereas severe COVID-19 pneumonia can result from insufficient IFN-1. Moreover, SARS-CoV-2 spike protein and robust IFN-1 response are seen in the skin of patients with pandemic-associated pernio, suggesting an excessive innate immune skin response to SARS-CoV-2. Understanding the pathophysiology of this phenomenon may elucidate the host mechanisms that drive a resilient immune response to SARS-CoV-2 and could produce relevant therapeutic targets.

Publication types

  • Review

MeSH terms

  • Animals
  • COVID-19 / complications
  • COVID-19 / immunology*
  • Chilblains / complications
  • Chilblains / immunology*
  • Humans
  • Immunity, Innate
  • Interferon Type I / metabolism
  • SARS-CoV-2 / physiology*

Substances

  • Interferon Type I